Amsterdam, the Netherlands and Yokneam, Israel – Royal Philips (NYSE: PHG, AEX: PHIA) and RealView Imaging Ltd. announced that they have completed a clinical study that has demonstrated the feasibility of using an innovative live 3D holographic visualization and interaction technology to guide minimally-invasive structural heart disease procedures.
In the pilot study that involved eight patients and was conducted in collaboration with the Schneider Children’s Medical Center in Petach Tikva, Israel, RealView’s innovative visualization technology was used to display interactive, real-time 3D holographic images acquired by Philips’ interventional X-ray and cardiac ultrasound systems.
Virtual Reality Symposium 28 and 29 January 2014 - Fontys University / Eindhoven The Netherlands
Throughout this symposium there will be a live size hologram presentation, as well as interesting demonstrations by Philips and other companies at the stands.
See the Virtual Reality Symposium Program, Speakers'and more detailed information here.
Abonneren op:
Reacties posten (Atom)
Geen opmerkingen:
Een reactie posten